Current Cancer Drug Targets, Volume 12 - Number 1

Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery

, 12(1): 1 - 13

G. Kauselmann, A. Dopazo and W. Link

DOI: 10.2174/156800912798888947

Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma

, 12(1): 14 - 22

H. Miyamoto, Y. Zheng and K. Izumi

DOI: 10.2174/156800912798888965

The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis

, 12(1): 23 - 43

A. Amini, S. Masoumi Moghaddam, D. L. Morris and M. H. Pourgholami

DOI: 10.2174/156800912798888956

Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations

, 12(1): 44 - 50

C. F. Singer, P. Zabkova, C. Rappaport, D. Muhr, G. Pfeiler, D. Gschwantler-Kaulich, A. Fink-Retter, C. Staudigl, I. Walter, G. Hudelist, A.-C. Spiess and E. Kubista

DOI: 10.2174/156800912798888938

The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells

, 12(1): 51 - 63

H. Herrmann, M. Kneidinger, S. Cerny-Reiterer, T. Rulicke, M. Willmann, K. V. Gleixner, K. Blatt, G. Hormann, B. Peter, P. Samorapoompichit, W. Pickl, G. Y. Bharate, M. Mayerhofer, W. R. Sperr, H. Maeda and P. Valent

DOI: 10.2174/156800912798888992

Targeting Urokinase and the Transferrin Receptor with Novel, Anti-Mitotic N-Alkylisatin Cytotoxin Conjugates Causes Selective Cancer Cell Death and Reduces Tumor Growth

, 12(1): 64 - 73

K. L. Vine, V. Indira Chandran, J. M. Locke, L. Matesic, J. Lee, D. Skropeta, J. B. Bremner and M. Ranson

DOI: 10.2174/156800912798888983

Knockdown of Insulin-Like Growth Factor I Receptor Inhibits the Growth and Enhances Chemo-Sensitivity of Liver Cancer Cells

, 12(1): 74 - 84

Y.-W. Zhang, D.-L. Yan, W. Wang, H.-W. Zhao, X. Lu, J.-Z. Wu and J.-R. Zhou

DOI: 10.2174/156800912798888974

Webmaster Contact:
Copyright © 2018 Bentham Science